Organon (OGN) Tops Q1 EPS by 6c, Offers Guidance

Organon (NYSE: OGN) reported Q1 EPS of $1.36, $0.06 better than the analyst estimate of $1.30. Revenue for the quarter came in at $1.57 billion versus the consensus estimate of $1.52 billion.

GUIDANCE:

Organon sees FY2022 revenue of $6.1-6.4 billion, versus the consensus of $6.26 billion.

For earnings history and earnings-related data on Organon (OGN) click here.

You May Also Be Interested In

• Kroger (KR) Reports In-Line Q1 EPS, Beats on Revenue; Offers FY27 EPS Guidance
• Organon and Samsung Bioepis Expand Agreement to Commercialize PYZCHIVA® (ustekinumab), a Biosimilar Referencing STELARA® (ustekinumab) in Canada
• SpaceX receives Baa1 rating from Moody's with stable outlook